SYNTHESIS OF BIOLOGICALLY IMPORTANT CARBOHYDRATES

Information

  • Research Project
  • 3287644
  • ApplicationId
    3287644
  • Core Project Number
    R01GM035244
  • Full Project Number
    1R01GM035244-01
  • Serial Number
    35244
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/1985 - 38 years ago
  • Project End Date
    7/31/1988 - 35 years ago
  • Program Officer Name
  • Budget Start Date
    8/1/1985 - 38 years ago
  • Budget End Date
    7/31/1986 - 37 years ago
  • Fiscal Year
    1985
  • Support Year
    1
  • Suffix
  • Award Notice Date
    -
Organizations

SYNTHESIS OF BIOLOGICALLY IMPORTANT CARBOHYDRATES

This project is directed towards the development of new methodology for the chemical synthesis of biologically important carbohydrates, and the application of useful techniques for the convenient preparation of carbohydrate and related biomolecules and structural variants which are of potential biochemical and medicinal utility. Aspects of reactivity and chemical mechanism are explored concurrent with the synthetic endeavors. Fundamental studies in general synthetic methodology will focus on the application of organometallic reactions for functionalization and homologation of mono- and oligosaccharides, on deoxygenation and skeletal rearrangements for the preparation of deoxy and branched-chain sugars, on halogenation (especially fluorination) and amination of carbohydrates, on synthesis and the study of reactivity of amino-nitro sugars, and on progressive glycosylation of higher hetero-oligosaccharides. Biologically significant, structural categories in which these researches will be performed include aminodeoxy and aminopolydeoxy sugars, aminocyclitols, and deoxy sugars important in the arenas of antibiotics chemistry and bacterial antigen structure, carbohydrate components of glycoproteins and glycolipids, and cyclodextrin analogs. Specific targets which will be approached in addition to these methodological investigations are aminated, configurational analogs of the natural disaccharide Alpha,Alpha-trehalose that show promise as antituberculous agents; chiral derivatives of 2-deoxy-streptamine for use in aminoglycoside antibiotics synthesis and mutasynthesis; and new, carbohydrate-modified analogs of antitumor-active anthracyclines, which may show enhanced activity or diminished toxicity.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R01
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    UNIVERSITY OF OTTAWA
  • Organization Department
  • Organization DUNS
  • Organization City
    OTTAWA
  • Organization State
    ON
  • Organization Country
    CANADA
  • Organization Zip Code
    K1N 6N5
  • Organization District
    CANADA